Switch to:
Also traded in: Australia, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» HTWR's 30-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

HTWR Guru Trades in Q4 2015

Jim Simons 50,000 sh (New)
Steven Cohen Sold Out
» More
Q1 2016

HTWR Guru Trades in Q1 2016

Michael Price 30,000 sh (New)
Jim Simons 192,448 sh (+284.90%)
» More
Q2 2016

HTWR Guru Trades in Q2 2016

Mario Gabelli 58,550 sh (New)
Paul Tudor Jones 55,000 sh (New)
Chuck Royce 10,000 sh (New)
Michael Price Sold Out
Jim Simons 181,700 sh (-5.58%)
» More
Q3 2016

HTWR Guru Trades in Q3 2016

Paul Tudor Jones Sold Out
Mario Gabelli Sold Out
Jim Simons Sold Out
Chuck Royce Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with HTWR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mario Gabelli 2016-09-30 Sold Out 0.02%$57.42 - $58 $ 57.980%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices  
Compare:NAS:CSII, NAS:KTWO, NAS:XENT, NAS:BABY, NYSE:CRY, NAS:TCMD, NAS:AXGN, NAS:CNMD, NYSE:ITGR, NAS:CUTR, NYSE:IVC, NAS:MDXG, NAS:GNMK, NAS:EXAC, NAS:ARAY, NAS:VRAY, NAS:SPNC, AMEX:CVRS, NAS:RTIX, ASX:RVA » details
Traded in other countries:HIN.Australia, HIY1.Germany,
Headquarter Location:USA
Heartware International Inc is a medical device company. It develops and manufactures small implantable heart pumps, or ventricular assist devices, for the treatment of heart failure.

Heartware International Inc was incorporated in Delaware on July 29, 2008 and became the successor issuer to HeartWare Limited, an Australian corporation, on November 13, 2008, as a result of the Australian Court approved redomiciliation of HeartWare Limited from Australia to Delaware. HeartWare is a medical device company engaged in developing implantable blood pumps for the treatment of advanced heart failure. The Company operates one reportable segment which includes the design, manufacture and marketing of medical devices for the treatment of advanced heart failure. The HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients with advanced heart failure. Beyond the HeartWare System, the company is also evaluating its next device, the Miniaturized Ventricular Assist Device. The MVAD is based on the same technology platform as the HeartWare System but adopts an axial flow, rather than a centrifugal flow, configuration and is being developed in multiple configurations. The MVAD designs are currently at the preclinical stage and undergoing animal studies focused on minimally invasive implantation techniques and are each approximately one-third the size of the HVAD Pump. The Company's competitors in the implantable cardiac assist space include Thoratec Corporation, Jarvik Heart, Inc., MicroMed Cardiovascular, Berlin Heart GmbH, and Sunshine Heart, Inc. HEARTWARE, HVAD, MVAD, PAL, CIRCULITE, SYNERGY and various company logos are the trademarks of the Company, in the United States, Europe, Australia and other countries.

Ratios

vs
industry
vs
history

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

More Statistics

Revenue (TTM) (Mil) $257.05
EPS (TTM) $ -3.40
Short Percentage of Float5.11%
52-Week Range $25.02 - 87.38
Shares Outstanding (Mil)17.56

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 240 260 307
EPS ($) -3.66 -2.97 -2.32
EPS without NRI ($) -3.66 -2.97 -2.32
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}